Angelmicin b, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cells
Akihiro Yokoyama(SHOWA Medical University), Yoshio Honma(National Cancer Center Hospital East), Junko Okabe‐Kado(Saitama Cancer Center), Shigeru Tomoyasu(Saitama Cancer Center), TOSHIKAZU OKI(Central Research Laboratories (United Kingdom)), Yoshimasa Uehara(Iwate Medical University), Nobuyoshi Tsuruoka(SHOWA Medical University)
Cited by 15
Related Papers
1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.
|Proceedings of the National Academy of Sciences|1983|255
Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative
|Journal of Lipid Research|2004|156
Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids
|Biochemical and Biophysical Research Communications|1980|120
Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase
|Biochemical and Biophysical Research Communications|1992|110